Androgenic alopecia
From Wikipedia, the free encyclopedia
 |
This article may contain original research or unverified claims. Please improve the article by adding references. See the talk page for details. (November 2008) |
| Androgenic alopecia | |
| Classification and external resources | |
 |
|
|---|---|
| Male pattern baldness in the 40-year-old tv host, Stefano Torkos. | |
| ICD-10 | L64. |
| DiseasesDB | 7773 |
| eMedicine | derm/21 |
Androgenic alopecia (also known as androgenetic alopecia or alopecia androgenetica) is a common form of hair loss in both female and male humans, chimpanzees, and orangutans.[1] In male humans in particular, this condition is also commonly known as male pattern baldness. Hair is lost in a well-defined pattern, beginning above both temples. Over time, the hairline recedes to form a characteristic "M" shape. Hair also thins at the crown of the head. Often a rim of hair around the sides and rear of the head is left, or the condition may progress to complete baldness.
The pattern of hair loss in women differs from male pattern baldness. In women, the hair becomes thinner all over the head, and the hairline does not recede. Androgenic alopecia in women rarely leads to total baldness.
Contents |
[edit] Cause
A variety of genetic and environmental factors are likely play a role in causing androgenic alopecia. Although researchers are studying the factors that may contribute to this condition, most of these remain unknown. Researchers have determined that this form of hair loss is related to hormones called androgens, particularly an androgen called dihydrotestosterone (DHT). Androgens are important for normal male sexual development before birth and during puberty. Androgens also have other important functions in both males and females, such as regulating hair growth and sex drive.
Male pattern baldness is caused by a genetic sensitivity of hair follicles to DHT, which causes them to shrink when exposed to it. This shortens their lifespan and prevents them from producing hair normally.[2]
[edit] Hair loss and genetics
Much research has gone into the genetic component of male pattern baldness, or androgenic alopecia (AGA). Research indicates that susceptibility to premature male pattern baldness is largely X-linked. Other genes that aren’t sex linked are also involved.
Large studies in 2005 and 2007 stress the importance of the maternal line in the inheritance of male pattern baldness. German researchers name the androgen receptor gene as the cardinal prerequisite for balding[3]. They conclude that a certain variant of the androgen receptor is needed for AGA to develop. In the same year the results of this study were confirmed by other researchers [4]. This gene is recessive and a female would need two X chromosomes with the defect to show typical male pattern alopecia. Seeing that androgens and their interaction with the androgen receptor are the cause of AGA it seems logical that the androgen receptor gene plays an important part in its development.
Other research in 2007 suggests another gene on the X chromosome, that lies close to the androgen receptor gene, is an important gene in male pattern baldness. They found the region Xq11-q12 on the X-chromosome to be strongly associated with AGA in males. They point at the EDA2R gene as the gene that is mostly associated with AGA.
Other genes involved with hair loss have been found. One of them being a gene on chromosome 3. The gene is located at 3q26[5]. This gene is recessive .
Another gene that might be involved in hair loss is the P2RY5. This gene is linked to hair structure. Certain variants can lead to baldness at birth, while another variant causes "wooly hair."
In May 2009, researchers in Japan identified a gene, Sox21, that appears to be responsible for hair loss in people.[1]
[edit] Hormone levels correlated with androgenic alopecia
Men with androgenic alopecia typically have lower levels of total testosterone, higher levels of unbound/free testosterone, and higher levels of total free androgens including DHT.[6][7]
5-alpha-reductase is responsible for converting free testosterone into DHT. The genes for 5-alpha-reductase are known[8]. The enzymes are present predominantly in the scalp and prostate. Levels of 5alpha-reductase are one factor in determining levels of DHT in the scalp and drugs which interfere with 5alpha-reductase (such as finasteride, which inhibits the predominant type 2 isoform ) have been approved by the FDA as treatments for hair loss.
Sex hormone binding globulin (SHBG), which is responsible for binding testosterone and preventing its bioavailability and conversion to DHT, is typically lower in individuals with high DHT. SHBG is downregulated by insulin.
Increased levels of Insulin Growth Factor-1 (IGF-1) have been correlated to vertex balding [9]
High insulin levels seem the likely link between metabolic syndrome and baldness. Low levels of SHBG in men and non-pregnant women are also correlated with glucose intolerance and diabetes risk, though this correlation disappears during pregnancy. [10]
[edit] Hair loss and lifestyle
While genetic factors seem to play the principal role in the development and progression of androgenic alopecia, lifestyle also plays a minor role as demonstrated by the vast increase in male and female pattern baldness in Japan after World War II, when the country moved to a higher-calorie, higher-fat diet and a more sedentary lifestyle.[citation needed] Also, pattern baldness (androgenic alopecia) was either rare or non-existent among hunter-gatherer and other, less westernized societies eating in their traditional manner. [11]
Daily, vigorous aerobic exercise (as opposed to short workout periods designed to raise androgen levels and build muscle, or more sporadic exercise) has been shown to reduce baseline insulin levels as well as baseline total and free testosterone, significantly lowering baseline DHT.[12] It has been suggested that weight training may have a detrimental effect on hair by increasing testosterone levels; however, there is at least one study that indicates a decline in free testosterone as result of weight training.[13]
[edit] Evolutionary theories of Male Pattern Baldness
One theory, advanced by Muscarella and Cunningham[4], suggests baldness evolved in males through sexual selection as an enhanced signal of aging and social maturity, whereby aggression and risk-taking decrease and nurturing behaviours increase. This may have conveyed a male with enhanced social status but reduced physical threat, which could enhance ability to secure reproductive partners and raise offspring to adulthood.
In a study by Muscarella and Cunnhingham [4], males and females viewed 6 male models with different levels of facial hair (beard and mustache or none) and cranial hair (full head of hair, receding and bald). Participants rated each combination on 32 adjectives related to social perceptions. Males with facial hair and those with bald or receding hair were rated as being older than those who were clean-shaven or had a full head of hair. Beards and a full head of hair were seen as being more aggressive and less socially mature, and baldness was associated with more social maturity. A review of social perceptions of male pattern baldness has been provided by Henss (2001) [5] .
The assertion that male pattern baldness is intended to convey a social message is supported by the fact that pattern baldness is also common in other primates, and is often used to convey increased status and maturity. Gorillas evolved anatomically enlarged foreheads for this reason. This suggests that baldness could have evolved to enhance the apparent size of the forehead, and increase the area of the face to be displayed. It should also be noted that most ancestry primates had a shorter life-span, and as baldness usually occurs at a later stage in life, baldness could have been a sign of survival and longevity. Premature baldness could also have evolved in younger males to convey this message, which correlates with studies suggesting men with bald or receding hairlines were rated as older than those with a full head of hair.
Other evolutionary hypotheses include genetic linkage to beneficial traits unrelated to hair loss and genetic drift.
[edit] Diagnosis
Differential diagnosis involves eliminating other causes of hair loss (such as poisoning) and comparing the pattern of hair loss to a typical male pattern baldness progression.[14]
[edit] Treatments
While many people with male pattern baldness choose to accept the condition as they accepted their hair color or shape, there are baldness treatments which can reduce or halt hair loss, and in early stages or in rare cases, reverse it entirely. Treatments include:
- Minoxidil, the recommended second-line treatment[15]
- Topical Caffeine [16]
- Dutasteride and Ketoconazole are also 5-alpha reductase inhibitors, but as of 2009 have not been FDA-approved as hair loss treatments.
Hair transplantation (does not treat or stop pattern baldness per se, but takes baldness resistant hair from the back of the head and moves it to vertex or frontal hairline)
[edit] See also
- Hamilton-Norwood scale: The scale that rates the severity of androgenic alopecia in males.
- Ludwig scale: The scale that rates the severity of androgenic alopecia in females.
- Noncicatricial alopecia
[edit] References
- ^ "The latest on baldness cures" ([dead link] – Scholar search). Duke Health News. December 1994. http://findarticles.com/p/articles/mi_m0857/is_n6_v12/ai_16395133. Retrieved on 2009-01-09.
- ^ http://www.webmd.com/skin-problems-and-treatments/hair-loss/hair-loss-causes
- ^ Hillmer AM, Hanneken S, Genetic variation in the human androgen receptor gene is the major determinant of common early-onset Androgenic Alopecia (AGA). Department of Genomics, Life and Brain Center, University of Bonn, Bonn, Germany.
- ^ Levy-Nissenbaum E, Bar-Natan M, Confirmation of the association between male pattern baldness and the androgen receptor genr Danek Gartner Institute of Human Genetics, Sheba Medical Center, Tel Hashomer, Israel
- ^ Hillmer AM, Flaquer A, Genome-wide scan and fine-mapping linkage study of AGA reveals a locus on chromosome 3q26. Department of Genomics, Life and Brain Center, University of Bonn, D-53127 Bonn, Germany.
- ^ Stárka L, Cermáková I, Dusková M, Hill M, Dolezal M, Polácek V (2004). "Hormonal profile of men with premature balding". Exp. Clin. Endocrinol. Diabetes 112 (1): 24–8. doi:. PMID 14758568.
- ^ Demark-Wahnefried W, Lesko SM, Conaway MR, et al. (1997). "Serum androgens: associations with prostate cancer risk and hair patterning". J. Androl. 18 (5): 495–500. PMID 9349747. http://www.andrologyjournal.org/cgi/pmidlookup?view=long&pmid=9349747.
- ^ Ellis JA, Panagiotopoulos S, Akdeniz A, Jerums G, Harrap SB (2005). "Androgenic correlates of genetic variation in the gene encoding 5alpha-reductase type 1". J. Hum. Genet. 50 (10): 534–7. doi:. PMID 16155734.
- ^ Signorello LB, Wuu J, Hsieh C, Tzonou A, Trichopoulos D, Mantzoros CS (1999). "Hormones and hair patterning in men: a role for insulin-like growth factor 1?". J. Am. Acad. Dermatol. 40 (2 Pt 1): 200–3. doi:. PMID 10025745.
- ^ McElduff A, Hitchman R, McElduff P (2006). "Is sex hormone-binding globulin associated with glucose tolerance?". Diabet. Med. 23 (3): 306–12. doi:. PMID 16492215.
- ^ Cordain L, Eades MR, Eades MD (2003). "Hyperinsulinemic diseases of civilization: more than just Syndrome X". Comp. Biochem. Physiol., Part a Mol. Integr. Physiol. 136 (1): 95–112. doi:. PMID 14527633. http://linkinghub.elsevier.com/retrieve/pii/S1095643303000114.
- ^ Daly W, Seegers CA, Rubin DA, Dobridge JD, Hackney AC (2005). "Relationship between stress hormones and testosterone with prolonged endurance exercise". Eur. J. Appl. Physiol. 93 (4): 375–80. doi:. PMID 15618989.
- ^ Ara, I.; Perez-Gomez, J.; Vicente-Rodriguez, G.; Chavarren, J.; Dorado, C.; Calbet, J. A. L. (2006). "Serum free testosterone, leptin and soluble leptin receptor changes in a 6-week strength-training programme." ([dead link] – Scholar search). British Journal of Nutrition 96 (6): 1053–9. doi:. http://www.ingentaconnect.com/content/cabi/bjn/2006/00000096/00000006/art00009.
- ^ http://www.webmd.com/a-to-z-guides/hair-loss-diagnosis
- ^ http://www.webmd.com/a-to-z-guides/hair-loss-treatments
- ^ Fischer TW, Hipler UC, Elsner P (2007). "Effect of caffeine and testosterone on the proliferation of human hair follicles in vitro". Int. J. Dermatol. 46 (1): 27–35. doi:. PMID 17214716. http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-4632.2007.03119.x.
[edit] Bibliography
[edit] External links
- International Society of Hair Restoration Surgery Resources for finding doctors, and more information about hair loss. This is a trade organization aimed at the promotion of surgical solutions to hair loss.
- Scow DT, Nolte RS, Shaughnessy AF (April 1999). "Medical treatments for balding in men". Am Fam Physician 59 (8): 2189–94, 2196. PMID 10221304. http://www.aafp.org/afp/990415ap/2189.html.
- Commercial treatment reviews Examines hair loss products, and the claims made by their manufacturers.
- How Hair Replacement Works Covers oral medications, hair transplant surgery, and topical treatments.
- Alopecia UK
- Help 4 Alopecia
- [2] USA Today article examining the impact of baldness on career success.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
